177Lu-PSMA-617 Combined With Darolutamide in Neoadjuvant Treatment of High-risk Localized Prostate Cancer: a Prospective, Single-arm, Multi-center Clinical Trial

Conditions

• Prostate Cancer
• Prostate Cancer Patients

Interventions

• DRUG: Darolutamide combined with 177Lu-PSMA-617

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Collaborators

• [object Object]